| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CMO | Chief Medical Officer
2 companies
Donovan Joanne M. is a CMO at EWTX, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 17 sales. Those positions are worth an estimated $374K at current prices.
Our model assigns Donovan Joanne M. a middling insider score of 53/100, based on 10 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -24.5%.
Donovan Joanne M.'s largest disclosed position is in EWTX as CMO, worth about $374K. The recent filings there lean toward selling, a net 178,176 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 9,441 | $43.71 | $412,703.17 | -52.3% | - | - | |
| May 5, 2026 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 55,230 | $37.88 | $2,092,062.91 | -92.7% | +1.1% | - | |
| Apr 1, 2026 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 28,662 | $32.31 | $926,095.02 | -74.9% | - | - | |
| Mar 31, 2026 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 21,338 | $32.12 | $685,308.28 | -69.0% | +31.6% | - | |
| Mar 27, 2026 | EWTX Edgewise Therapeutics, Inc. | CMO | Sell | 16,358 | $30.98 | $506,734.85 | -63.0% | +35.2% | - | |
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 2,862 | $13.39 | $38,329.05 | -10.1% | +36.5% | - | |
| May 2, 2025 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 5,187 | $16.45 | $85,347.94 | -19.4% | -15.7% | +81.0% | |
| Jan 28, 2025 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 25,000 | $27.63 | $690,657.50 | -60.4% | -43.6% | +3.2% | |
| Sep 20, 2024 | EWTX Edgewise Therapeutics, Inc. | CMO | Sell | 7,162 | $28.29 | $202,602.95 | -33.0% | +8.9% | -49.6% | |
| May 2, 2024 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 3,682 | $18.91 | $69,626.62 | -15.6% | -11.7% | -12.3% |